TOMMY RUSHING: Open Payments
NPI 1992223713 · DOTHAN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,862 in 128 payments from 46 companies in 2025. Trend: 2023 $1,271 · 2024 $2,027 · 2025 $2,862
Food & beverage: $2,763Education: $99
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 6 | $226 |
| BeOne Medicines USA, Inc. | 4 | $192 |
| Genentech USA, Inc. | 9 | $179 |
| Regeneron Healthcare Solutions, Inc. | 7 | $163 |
| E.R. Squibb & Sons, L.L.C. | 7 | $142 |
| AstraZeneca Pharmaceuticals LP | 7 | $134 |
| Novartis Pharmaceuticals Corporation | 6 | $126 |
| Daiichi Sankyo Inc. | 5 | $107 |
| SEAGEN INC. | 1 | $99 |
| Merck Sharp & Dohme LLC | 4 | $88 |
Products named: BRUKINSA, OPDIVO, LIBTAYO, Zynyz, KEYTRUDA, Tecentriq, Enhertu, VERZENIO.
Industry payments across AL — which companies pay providers there.
